Segall Bryant & Hamill, LLC Avid Bioservices, Inc. Transaction History

Segall Bryant & Hamill, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$9.4 - $14.04 $31,508 - $47,062	-3,352 Reduced 0.69%	480,655 $4.54 Million
Q2 2023 Aug 11, 2023	BUY	$12.96 - $20.93 $31,596 - $51,027	2,438 Added 0.51%	484,007 $6.76 Million
Q1 2023 May 15, 2023	BUY	$13.48 - $18.79 $1.25 Million - $1.75 Million	93,041 Added 23.95%	481,569 $9.03 Million
Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $4.9 Million - $7.28 Million	388,528 New	388,528 $5.35 Million
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $5.54 Million - $7.36 Million	361,558 New	361,558 $6.91 Million
Q2 2022 Aug 15, 2022	BUY	$11.63 - $21.55 $910,489 - $1.69 Million	78,288 Added 42.15%	264,013 $4.03 Million
Q1 2022 May 13, 2022	BUY	$16.63 - $27.73 $3.09 Million - $5.15 Million	185,725 New	185,725 $3.78 Million

184

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $770M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.